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Induced pluripotent stem cells (iPSCs) are generated by directly reprogramming 
somatic cells by forcing them to express the exogenous transcription factors, Oct4, 
Sox2, Klf4 and c-Myc (OSKM). These cells could potentially be used in clinical 
applications and basic research. Here, we explored the molecular role of Sox2 by 
generating iPSCs that expressed Sox2 at various levels. Low Sox2 (LS) expression 
increased the efficiency of generating partially reprogrammed iPSCs in combination 
with OKM. Notably, we detected a significant increase in the number of fully 
reprogrammed iPSCs with three factors of OK and LS. LS expression was linked with 
the reduced expression of ectoderm and mesoderm marker genes. This indicates that 
cell differentiation into the ectoderm and mesoderm lineages was impeded during 
reprogramming. The quality of the iPSCs that was generated by using OK and LS was 
comparable to that of iPSCs that were produced via conventional OSK as seen by 
pluripotent marker gene expression and chimera formation. We conclude that Sox2 
plays a crucial role in a dose-dependent manner in directly reprogramming of somatic 






Reprogramming somatic cells into pluripotent embryonic stem cell (ESC)-like cells is 
achieved by the transduction using a defined set of transcription factors: Oct4 (Pou5f1), 
Sox2, Klf4 and c-Myc (OSKM) [1,2]. Induced pluripotent stem cells (iPSCs) can also 
be established in the absence of a transduced c-Myc (OSK) [3] or by using other 
combinations of factors [4,5]. Although the generating iPSCs is technically simple and 
ethically acceptable, transgene integration is problematic for clinical applications. 
Recently, several groups have reported on the generating iPSCs without having to use 
viral vectors [6,7]. However, a major issue with their approaches is the low efficiency 
of producing iPSCs. Uncovering the function of reprogramming factors would be 
helpful for improving the efficiency of direct reprogramming. 
     Two reprogramming factors, Oct4 and Sox2, are core regulatory factors that 
function cooperatively with Nanog in both human and mouse ESCs [8,9]. Oct4 has 
been studied at length and is recognized as being essential for the early development 
and maintenance of pluripotency. Oct4-deficient embryos fail to form an inner cell 
mass [10]. Reduced Oct4 expression in ESCs causes them to differentiate into the 
trophectoderm, while doubly high expression induces differentiation into the primitive 
endoderm and mesoderm [11]. Sox2, which is a high-mobility group DNA-binding 
domain transcription factor, is also essential for early embryogenesis in mice [12]. The 
twenty genes that comprise the mouse Sox-family are classified into ten subgroups, 
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whereby Sox2 is categorized into group B1 [13]. Sox2 could be substituted for using 
Sox1 or Sox3 to generate iPSCs [3], even if low expression of these two genes occurs 
in ESCs. Sox2 is expressed in the developing central nervous system and maintains the 
properties of neural precursor cells [14]. Oct4 and Sox2 cooperatively bind to and 
activate the transcription of genes that bear Octamer and Sox elements, such as Oct4, 
Sox2, Nanog, Fgf4, Utf1 and Lefty1 [15-20]. Similar to Oct4, Sox2 depletion and 
overexpression promotes differentiation. A two-fold or less increase in Sox2 reduces 
the transcription of Oct4/Sox2 target genes in ESCs. This results in differentiation into 
various lineages, including the ectoderm and mesoderm [21-23], while the knockdown 
of Sox2 induces differentiation into endoderm and trophectoderm lineages [23-25]. 
Therefore, precisely regulating the expression of the transcription factors is crucial to 
maintain the pluripotent state of ESCs. However, the effects of quantitative changes in 
reprogramming factors when inducing pluripotent stem cells remain poorly understood. 
     Here, we examined the suppressive effects of excessive Sox2 on direct 
reprogramming. Decreased Sox2 virus led to a marked increase in the number of Oct4-
GFP-positive cells. However, resulting cell fates were different depending on whether 
the transduction occurred with or without c-Myc (OSKM and OSK). For OKM and 
reduced Sox2, the majority of the GFP-positive colonies was trapped in a partially 
reprogrammed state, while for OK and reduced Sox2, most of the cells turned into 
fully reprogrammed iPSCs. A significant increase in the number of differentiation 
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markers, which depended on the level of Sox2, was indicative that excessive Sox2 
expression promotes differentiation into the mesoderm or ectoderm in parallel with 
reprogramming. Thus, our data is supportive that the appropriate expression of Sox2 is 
critical for efficiently generating iPSCs. 
 
Results 
Expression control through the amount of virus 
To investigate the effect of Sox2 expression on the reprogramming process, mouse 
embryonic fibroblasts (MEFs) were infected with various amounts of Sox2 virus. We 
used two lines of experiments, one experiment which utilized the mock virus (the 
empty retroviral pMX vector), and the other which did not, to understand the 
efficiency of viral infection. The results of quantitative Western blotting analysis were 
indicative that the amount of Sox2 protein corresponded to the amount of Sox2 virus 
that was present in OSKM and OSK during viral infection (Fig. 1).  Interestingly, no 
obvious difference in Sox2 expression was detected between the experiment that 
entailed using the mock virus and that which did not. Furthermore, an increase in Sox2 
to 200% resulted in a decrease in Oct4 (Fig. 1). This is suggestive that excessive viral 
Oct4 and Sox2 proteins interacted with one another during transcription, translation or 
degradation regulation. It is possible that this Oct4 and Sox2 interaction may conceal 
the difference in the total amount of virus between the experiments that used the mock 
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virus compared to which did not. Therefore, we performed OSKM and OSK infection 
without mock.  
 
Reprogramming by OKM plus low Sox2 
MEFs from Oct4-GFP ⁄ Neo-LacZ (Rosa26) double-transgenic mouse embryos were 
prepared to evaluate the efficiency of reprogramming. GFP expression is driven by the 
Oct4 promoter [26], while LacZ is ubiquitously expressed in the double-transgenic cell 
[27]. MEFs were split into several groups and infected with OSKM at various 
concentrations of Sox2 virus. Kinetic analysis of GFP-positive cells on days 6, 8 and 
10 after infection was indicative that the increased reprogramming efficiency was most 
effective at the 20% Sox2 (LS) (Fig. 2A, B). The number of GFP-positive cells had 
increased about five times for OKM and LS (OKM+LS) when compared to 
conventional OSKM by using fluorescence-activated cell sorting (FACS) analysis 
(Supplementary Fig. 2A). For 10% and 200% Sox2, the reprogramming efficiency 
decreased compared to conventional OSKM on day 10 (Fig. 2B).  To examine whether 
the increase of GFP-positive cells improved the generation efficiency to fully 
reprogrammed iPSCs, which were defined by the stable GFP expression and 
maintenance of undifferentiated state, each GFP-positive clone that was picked up was 
cultured for a month. Notably, fifteen fully reprogrammed clones were established out 
of seventy-two clones (20.8%) for conventional OSKM, while nine out of ninety-two 
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clones (9.4%) were established for OKM+LS (Fig. 2C). The OKM+LS infection 
resulted in a prominent increase in GFP-positive partially reprogrammed iPSCs. 
However, there was no significant increase in the number of fully reprogrammed 
iPSCs. In total, the reprogramming efficiency for MEFs being changed into fully 
reprogrammed iPSCs was not significantly improved.  
     The expression of lineage and pluripotent marker genes was then examined using 
quantitative reverse transcription-PCR (qPCR) to characterize differentiating cells and 
GFP-positive cells that were generated by reprogramming with OKM+LS. For 
pluripotent marker genes, Fgf4, Utf1, Rex1, Eras and Sall4 expression was high for 
OKM+LS rather than for OSKM (Supplementary Fig. 1A-C). For the lineage marker 
genes, mesoderm marker expression including that of Flk1, Gremlin and Myh2, and 
ectoderm marker expression including that of Nestin, Sox13, Sox21 and CryM was 
significantly low for OKM+LS compared to OSKM on day 3 (Supplementary Fig. 1D). 
However, the expression of endoderm and trophectoderm makers was not. A similar 
situation was noted for on days 7 and 12 after infection (Supplementary Fig. 1E). 
Notably, partially reprogrammed iPSCs in OKM+LS (Supplementary Fig. 2B) were 
characterized as having low expression of Sox2, Nanog and Fgf4, and high c-Myc, 
Sox17 and Desmin expression (Supplementary Fig. 2C). Taking these findings into 
consideration, excessive Sox2 expression for conventional OSKM induces 
differentiation of reprogramming cells into the ectoderm and mesoderm lineages, at 
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least in part, in a Sox2-dependent manner.  
      Three fully reprogrammed OKM+LS iPSC lines (#1~#3) that were characterized 
using Oct4-GFP expression (Supplementary Fig.3A), pluripotent marker gene 
expression (Supplementary Fig. 3B), and pluripotent marker protein expression 
(Supplementary Fig. 3C) were pluripotent. This was revealed by contribution to the 
three primary layers and germ cells of an E12.5 chimeric embryo, for which two 
chimeras out of five embryos were obtained with the #2 iPSC line (Supplementary Fig. 
3D). 
 
Reprogramming by OK plus low Sox2 
The improved reprogramming efficiency for changing MEFs into fully reprogrammed 
iPSCs was unclear with OKM+LS. Therefore, we examined the reprogramming 
efficiency in OK and various concentrations of Sox2 to exclude the effect of c-Myc. 
The number of GFP-positive colonies with Sox2 at 200%, 100%, 50%, 20% and 10% 
was counted (Fig. 2D). Excessive (200%) and extremely low (10%) Sox2 resulted in 
no significant improvement in the reprogramming efficiency. For OK+20% Sox2 (LS), 
the number of GFP-positive colonies was 3.3 times higher than for OSK on day 10 of 
infection. Notably, a similar tendency was detected consecutively on days 12, 14 and 
16 (Fig. 2D). The rate for establishing fully reprogrammed iPSCs for OK+LS at 57% 
was comparable to that for conventional OSK at 52% (Fig. 2E). No increase in the 
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number of partially reprogrammed cells was observed for OK+LS (data not shown). 
Taking these findings into consideration together, the net generation efficiency of fully 
reprogrammed iPSCs for OK+LS infection was approximately three times higher than 
for conventional OSK infection.  
 
Alternative cell fates induced by OK plus LS 
Pluripotent and lineage marker gene expression was analyzed using qPCR on day 3 
after infection to explore the cell fate on reprogramming by using OK+LS. Among the 
pluripotent marker genes, expression of the reprogramming factors, total Oct4 and 
Klf4, was markedly high, while that for total Sox2 was low for OK+LS (Fig. 3A). The 
Oct4/Sox2 target genes, Nanog, Lefty1, Fgf4 and Utf1 were highly expressed for 
OK+LS (Fig. 3B). In particular, Fgf4 expression was about seven times higher for 
OK+LS than for OSK. For other pluripotent markers, Rex1, Eras, Sall4 and Ronin 
were highly expressed for OK+LS (Fig. 3C).  
     Among the lineage marker gene expression for OK+LS was roughly similar to that 
for OSK (Fig. 3D). Specifically, the ectoderm markers, Sox13, Sox21 and CryM, and 
the mesoderm marker, Myh2 were significantly underexpressed. Endoderm marker, 
Sox17 was highly expressed for OK+LS compared to OSK. Next, temporal expression 
was analyzed using qPCR on days 3, 7 and 16 after infection. The expression of Myh2, 
Sox21 and CryM was extremely low for OK+LS compared to OSK on days 3, 7 and16 
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after infection. However, no significant changes were detected for Desmin and 
Gremlin (Fig. 3E). These data are supportive that induced cell differentiation into the 
ectoderm and mesoderm lineages was impeded for OK+LS. Consequently, the 
decreased generation efficiency of partial iPSCs contributed to the increased 
generation efficiency of fully reprogrammed iPSCs for OK+LS. 
 
Quality of iPSCs generated through OK plus low Sox2 
The quality of fully reprogrammed iPSCs that were obtained using OK+LS was tested. 
The analyses included examining the following: colony morphology; uniform Oct4-
GFP expression (Fig. 4A); expression of pluripotent marker gene expression: Nanog, 
Rex1, Stella, Lefty1, Eras, Gdf3, Fgf4, Utf1 and Sall4 RT-PCR analyses (Fig. 4B); and 
immunocytochemical analyses of Nanog, Oct4, Sox2, SSEA-1, Stella, and E-cadherin 
(Fig. 4C) in all #1~3 OK+LS-iPSC lines. The resulting data were indicative that the 
iPSCs with OK+LS were comparable to iPSCs with conventional OSK in vitro.  
     Three LacZ-positive iPSC lines, which have the normal karyotype 2n=40 and Gtl2 
expression [28], were selected from twenty-two iPSC cell lines that were examined to 
determine pluripotency of the OK+LS-iPSCs in vivo. They were then microinjected 
into blastocysts. A contribution to the three germ layers of morphologically normal 
E15.5 or E16.5 chimeric embryos was detected by using X-galactosidase (Gal) 
staining for all three OK+LS-iPSC lines. One chimera out of four embryos for the 
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iPSC line #1, one out of eighteen for line #2, and seven out of eleven for line #3 were 
observed (Fig. 4D). X-gal-positive germ cells that were found in the testicular tubules 
of E16.5 chimeric embryos were indicative of the germ cell competence of OK+LS-
iPSCs (Fig. 4D). Therefore, the OK+LS iPSCs were comparable to conventional 
iPSCs in terms of pluripotency.  
 
Discussion 
A simple method for decreasing Sox2 virus improved the efficiency of Oct4-GFP-
positive cells to emerge for OKM+LS and OK+LS. This is indicative of the 
attenuating effects on the reprogramming efficiency of overexpressed Sox2 for 
conventional OKSM and OKS. The increased reprogramming efficiency for LS 
resulted from the decreased cell differentiation of MEFs into ectoderm and mesoderm 
lineages as observed by using qPCR analyses. The increased number of GFP-positive 
cells for OKM+LS was caused by the increase in partially reprogrammed iPSCs. 
Improved reprogramming efficiency of somatic cells into fully reprogrammed iPSCs 
was significant for OK+LS. These data are indicative that 1) the reprogramming 
efficiency of MEFs into iPSCs was significantly increased by low level Sox2 
expression in a dose-dependent manner: 2) improved reprogramming efficiency for 
reprogramming into iPSCs by using OK+LS was associated with impeding cell 
differentiation of MEFs into the ectoderm and mesoderm lineages: and 3) the 
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generation efficiency of partial iPSCs decreased through reprogramming with OK+LS.      
    Partial iPSCs were dominantly induced with OKM+LS but not with OK+LS. c-Myc 
plays a role in controlling the transcription activity of numerous genes that are related 
to dedifferentiation and proliferation [29,30]. The strong transforming activity of c-
Myc induces clonal expansion of the reprogramming cells for OKM+ LS (Fig. 5A). 
Thus, partial iPSC generation that induced with c-Myc masked the positive effect of 
LS. In the case of the iPSC induction without c-Myc, the improved effect of LS on the 
reprogramming efficiency became more apparent by the excluding the partial iPSCs 
(Fig. 5B). 
     In mice, neural stem cells (NSCs) that express endogenous Sox2 are successfully 
reprogrammed into iPSCs only by using OKM infection [31,32]. Interestingly, the 
reprogramming efficiency of NSCs was decreased by addition of Sox2 into OKM, such 
that excessive Sox2 expression interfered with reprogramming. In humans, 
reprogramming efficiency is improved by increasing the amount of Oct4-expressing 
lentivirus three-fold [33]. Furthermore, increased Sox2 virus down-regulated the 
efficiency of colony formation, while decreased Sox2 enhanced this efficiency. 
Exogenous Sox2 expression is essential for acquiring pluripotency among somatic 
cells through reprogramming in humans and the mouse [1,34]. These data are 
consistent with our findings. Thus, an appropriate level of Sox2 expression is 
important to induce the efficient reprogramming.  
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     Sox2 plays an essential role in mouse development. For example, it is involved in 
patterning of the anterior foregut, maintaining postnatal NSCs, neurogenesis in the 
brain, and the eye formation [14,35,36]. Interestingly, Sox2 functions in a dose-
dependent manner in vivo. In the endoderm, the region that highly expresses Sox2 
differentiates into the pharynx and esophagus. In the region where it is underexpressed, 
it becomes the trachea [35]. In the ectoderm, the heterozygotic loss of Sox2 does not 
induced an obvious phenotype. However, a <40% reduction in Sox2 induces aberrant 
neural progenitor differentiation, which results in microphthalmia [36]. Thus, Sox2 
plays a key role in differentiation into the ectoderm, mesoderm and endoderm lineages 
in a dose-dependent manner in vivo. It seems that dose-dependent effects of Sox2 are 
common for in vivo development and in vitro reprogramming. However, a few 
changes in endoderm-related gene expression were detected for OKM+LS and OK+LS. 
In ESCs, forced up-regulation of Sox2 results in no significant changes in the 
expression of endoderm-related genes [22]. This is suggestive that a dose-dependent 
effect of Sox2 on the induction of endoderm lineage differentiation may not be obvious 
for direct reprogramming in vitro.  
     The molecular mechanisms that are involved in inducing of alternative cell fates by 
increasing and reducing the amount of Sox2 during reprogramming remain unclear. An 
interesting finding was that Oct4 changes its partner and targets genes in a dose-
dependent manner in human ESCs [37]. Excessive expression of Oct4 in human ESCs 
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leads to differentiation into a cardiac cells through switching of the binding element 
that is located to Sox17 from the Sox2 promoter. It is possible that switching protein 
interaction partners and binding affinity to regulatory elements of downstream genes, 
which changes cell fate, occurs in Sox2 in a dose-dependent manner, similar to that of 
Oct4. The qPCR analyses that are discussed here were evaluated using RNA that was 
extracted from heterogeneous populations through reprogramming that was induced 
using defined factors. Further comparisons of expression profiles between colonies 
could be helpful for understanding the molecular events that underlie the dose-
dependent effect of Sox2.  
     We conclude that the significantly increased generation efficiency of fully 
reprogrammed iPSCs via OK+LS resulted from efficient reprogramming into fully 
reprogramming iPSCs following a significant increase in Oct4-GFP-positive iPSCs. 
Optimizing the dose of reprogramming factors will be a key to realizing practical 
applications of recently developed integration-free and genetic modification-free 
reprogramming technologies.  
 
Materials and methods 
Cell culture 
Mouse iPSCs or ESCs were maintained in DMEM/F12 (Dulbecco’s modified Eagle’s 
medium/Ham’s F12, Wako Chemical, Osaka, Japan), which was supplemented with 
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15% fetal bovine serum (FBS; Gibco, Carlsbad, CA), 10-4 M 2-mercaptoethanol, and 
400 units/ml recombinant LIF (Chemicon, Temecula, MA). The cells were maintained 
on MEFs feeder cells that had been inactivated with mitomycin C. To isolate double-
transgenic MEFs, E12.5 embryos were minced with an 18-gauge needle after being 
obtained from GOD-18/delta PE/GFP (Oct4-GFP) transgenic females [26] that had 
been mated with 129/Rosa26 transgenic males [27]. The resulting cell suspension was 
plated and cultured with DMEM (Sigma Aldrich, St. Louis, MO) containing 10% FBS. 
MEFs were used during early passages. 
iPSC induction from MEFs 
Retroviral supernatants for Oct4, Sox2, Klf4 and c-Myc were collected from PlatE 
packaging cells and stored at –80°C prior to being used for infection. Titers for Oct4 
and Sox2 but not Klf4 and c-Myc virus were determined by using immunocytochemical 
analyses of MEFs at 36 hours after infection. Oct4 and Sox2 virus were used at the 
same multiplicity of infection (MOI) of 3 for OSKM or OSK transduction. MEFs were 
seeded on gelatin-coated 12-well culture plates at 4 x 104 cells per well, and were 
infected with a mixture of stocked viral supernatant with 4 µg/mL polybrene (day 0) to 
determine the reprogramming efficiency. The medium was replaced with ESC medium 
on day 1. All GFP-positive colonies in each well were counted among days 4-12 for 
OSKM, and days 6-16 for OSK. Infected cells were reseeded on a feeder layer on day 
4 and picked up on day 14 for OSKM or day 20 for OSK, to establish iPSCs. 
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Western blot hybridization 
Whole cell lysate was extracted from MEFs on day 3 after infection. Total protein (5 
µg) was separated by using10% SDS-polyacrylamide gel electrophoresis and 
transferred onto a nitrocellulose membrane (Millipore, Billerica, MA). It was 
subsequently reacted with anti-Oct4 (1:100 dilution), anti-Sox2 (1:2000), or anti-beta-
actin (1:2000) antibodies at 4°C overnight. The membranes were then incubated with a 
secondary antibody (1/3000; GE Healthcare, Little Chalfont, Buckinghamshire, U.K.) 
for one hour and the signals were then detected by using the ECL Western blotting 
detection kit (GE Healthcare). 
Immunocytochemistry 
Cells that were fixed with 4% paraformaldehyde in phosphate-buffered saline (PBS) 
for 15 minutes at room temperature were pre-treated with blocking solution at 4 °C 
overnight. The blocking solution was composed of PBS containing 3% BSA (Sigma), 
2% skim milk (DIFCO, Detroit, MI), and 0.1% Triton X-100. The cells were then 
stained with fluorescence-conjugated secondary antibody (1/500; Invitrogen), 
following to immunoreaction with anti-Oct4 (1:50), anti-Nanog (1:1000), anti-Sox2 
(1:1000), anti-Stella (1:500), anti-SSEA1 (1/1000), or anti-E-Cadherin (1/1000) at 4°C 
overnight. 
Mouse chimeric embryos 
OKM+LS- and OK+LS-iPSCs were microinjected into C57BL/6J or 
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(C57BL/6JxBDA)F2 blastocysts and then transferred into the uteruses of pseudo-
pregnant ICR females. E12.5, E15.5 and E16.5 embryos were collected and stained 
according to X-Gal staining procedures [38].  
Flow Cytometry  
Cells were dissociated into single cells with 0.25% trypsin/ 0.4% EDTA/ PBS, washed 
once, re-suspended in PBS with 2% FBS, and analyzed using a FACS Vantage system 
(Becton Dickinson, Franklin Lakes, NJ). 
Quantitative reverse transcription-PCR (qPCR)  
Total RNA was extracted using TRIzol (Invitrogen, Carlsbad, CA) according to the 
manufacturer’s instructions. DNase I (Roche Diagnostics, Basel, Switzerland)-treated 
RNA was reverse-transcribed by using random primers and Superscript III Reverse 
Transcriptase (Invitrogen). Amplification was performed using the Prism 7700 
(Applied Biosystems, Foster City, CA) and Power SYBR Green PCR Master Mix 
(Applied Biosystems) according to the manufacturer’s instructions with gene-specific 
primer sets. All reactions were carried out in duplicate and gene expression levels were 
normalized to Gapdh. Relative expression of each gene was quantified from threshold 
cycles for amplification using the 2ΔΔCt method. The primer sets that were used are 
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Figure 1.  Expression of Sox2 in virus dilution series.  The expression of Sox2, Oct4, 
and β-Actin (control) in mouse embryonic fibroblasts on day 3 after OSKM (Oct4; 
Sox2; Klf4; c-Myc) or OSK infection was analyzed by using Western blotting 
hybridization. The ratio of the band intensity of Sox2 or Oct4 to β–Actin was 
calculated using Image J software (NIH).  
 
Figure 2.  Increase in the number of Oct4-GFP-positive cells for direct 
reprogramming by using OKM  (Oct4; Klf4; c-Myc) or OK with Sox2 at low 
expression level (LS). (A) GFP-positive iPSC colonies on day 10 after infection of 
OSKM (Sox2 100%) and OKM+LS (Sox2 20%).  The colonies are encircled by dotted 
lines. (B) Kinetic analysis of the number of Oct4-GFP-positive colonies with OSKM. 
The error bars that indicate S.E.M are hidden in the graph. 200% Sox2, S.E.M.= ±0.0 
(day 4), ±0.0 (day 6), ±3.6 (day 8), ±4.0 (day10); 100% Sox2, S.E.M.= ±0.0 (day 4), 
±0.8 (day 6), ±11.8 (day 8), ±14.1 (day10); 50% Sox2, S.E.M.= ±0.0 (day 4), ±3.1 (day 
6), ±18.7 (day 8), ±22.5 (day10); 20% Sox2, S.E.M.= 0.0 (day 4), ±3.8 (day 6), ±17.8 
(day 8), ±28.0 (day10); 10% Sox2, S.E.M.= ±0.0 (day 4), ±3.7 (day 6), ±19.9 (day 8), 
±16.5 (day10); 0% Sox2; S.E.M.= ±0.0 (day 4), ±0.0 (day 6), ±0.9 (day 8), ±0.2 
(day10). (C) The generation frequency of fully reprogrammed iPSCs by OSKM and 
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OKM+LS transduction.  (D) Kinetic analysis of the number of Oct4-GFP-positive 
colonies with OSK. The error bars that indicate S.E.M are hidden in the graph. 200% 
Sox2, S.E.M.= ±0.0 (day 8), ±0.0 (day 10), ±±0.0 (day 12), ±0.1 (day14), ±0.5 
(day16); 100% Sox2, S.E.M.= ±0.0 (day 8), ±0.5 (day 10), ±1.2 (day 12), ±2.6 (day14), 
±4.8 (day16); 50% Sox2, S.E.M.= ±0.0 (day 8), ±1.3 (day 10), ±3.7 (day 12), ±10.7 
(day14), ±8.3 (day16); 20% Sox2, S.E.M.= 0.0 (day 8), ±1.1 (day 10), ±3.3 (day 12), 
±6.6 (day14), ±8.0 (day16); 10% Sox2, S.E.M.= ±0.0 (day 8), ±0.6 (day 10), ±2.2 (day 
12), ±4.8 (day14), ±4.2 (day16); 0% Sox2, S.E.M.= ±0.0 (day 8), ±0.0 (day 10), ±0.0 
(day 12), ±0.0 (day14), ±0.1 (day16). (E) The generation frequency of fully 
reprogrammed iPSCs by OSK and OK+LS transduction. 
 
Figure 3. Expression of pluripotent and lineage marker genes in somatic cells that had 
been reprogrammed with Oct4, Klf4 (OK) and low level Sox2 (LS) expression as 
determined by using quantitative reverse transcription-PCR (qPCR) analysis. (A) 
Relative expression of reprogramming factors on day 3 after infection (day 3). The 
primer sets were designed to amplify both endogenous and transgenic expressions. n=5. 
(B-D) The relative expression of Oct4/Sox2 target genes on day 3 (n=5) (B), stem cell 
markers on day 3 (n=5) (C), and lineage-specific markers on day 3 (n=5) (D). (E) 
Kinetic analyses of gene expression relative to MEFs in lineage-specific genes on days 




Figure 4. Pluripotency of induced pluripotent stem cells established by using Oct4, 
Klf4, and low Sox2 (OK+LS-iPSCs). (A) Expression of Oct4-GFP in morphologically 
normal OK+LS-iPSCs. GFP expression was detected to be uniform in the cell colonies. 
(B) Expression of pluripotent marker genes in #1-3 OK+LS iPSC lines by using RT-
PCR. Gapdh was used as a loading control. The primer sets that were used are 
summarized in Supplementary Table 1. (C) The expression of pluripotent marker 
proteins by using immunostaining. The expression of Nanog, Oct4, Sox2, SSEA1, 
Stella and E-cadherin (Ecad) was detected as red signals. Nuclei were visualized by 
using 4’, 6-Diamidino-2-Phenylindole (DAPI). (D) Contribution of OK+LS- iPSCs 
derivatives in mouse E15.5 or E16.5 chimeric embryos. The iPSC derivatives were 
visualized as blue cells by using X-gal staining. Germ cells derived from iPSCs were 
detected as X-gal-positive cells in the testis of E15.5 #3 embryo (right panel). 
 
 
Figure 5. Schematic representation of the reprogramming effects of Sox2 at the low 
expression level (LS) with and without c-Myc on cell fate. (A) The reprogramming 
effect of Oct4, Klf4, c-Myc (OKM) and LS on cell fate. For conventional OSKM, the 
majority of transduction-mediated reprogramming cells undergoe differentiation to 
ectoderm and mesoderm lineages. A limited number of cells are changed into fully 
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reprogrammed induced pluripotent stem cells (iPSCs). For OKM and LS, the limited 
number of cells underwent differentiation into the ectoderm and mesoderm lineage, 
while the number of partially reprogrammed iPSCs significantly increased compared 
to the OSKM. Furthermore, no increase in the number of fully reprogrammed iPSCs 
was detected.  (B) The reprogramming effects of Oct4, Klf4 (OK) and LS on cell fate. 
For conventional OSK, a number of infected cells do not reprogram or differentiate 
into the ectoderm and mesoderm lineages. However, a limited number of cells are 
changed into fully reprogrammed iPSCs. For OK and LS, the number of fully 
reprogrammed cells significantly increases instead of there being a decrease in the 
number of cells that differentiate into the ectoderm and mesoderm lineages. 
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Supplementary Figure 1. Expression of pluripotent and lineage marker genes in 
somatic cells that had been reprogrammed with Oct4, Klf4, c-Myc (OKM) and the low 
Sox2 (LS) expression as determined by using quantitative reverse transcription-PCR 
(qPCR) analysis.  
(A) Relative expression of reprogramming factors on day 3 after infection. Primer sets 
were designed to amplify endogenous and transgenic expressions (n=6). (B-D) 
Relative expression of Oct4/Sox2 target genes on day 3 (n=6) (B), stem cell markers 
on day 3 (n=6) (C), and lineage markers on day 3 (n=6) (D). (E) Kinetic analyses of 
gene expression relative to MEFs for lineage marker genes on days 3, 7, and 12. TE, 
trophectoderm. * P < 0.05. Error bars, S.E.M.  
 
Supplementary Figure 2. Characteristics of partially reprogrammed induced 
pluripotent stem cells (partial iPSCs) that were established by using Oct4, Klf4, c-Myc 
(OKM) and low Sox2 (LS) expression. (A) The number of GFP-positive iPSCs on day 
7 after OSKM and OKM+LS transduciton by using FACS analysis. (B) Morphology 
of partial and fully reprogrammed iPSC colonies. Oct4-GFP is visualized as green. (C) 
Expression of pluripotent and lineage marker genes in partial iPSCs relative to ESCs. 
Error bars, S.E.M. 
 
Supplementary Figure 3. Pluripotency of induced pluripotent stem cells that were 
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established by using Oct4, Klf4, c-Myc, and low Sox2 (OKM+LS-iPSCs). (A) 
Expression of Oct4-GFP in morphologically normal OKM+LS-iPSCs. GFP expression 
was detected as being uniform in the cell colonies. (B) Expression of pluripotent 
marker genes in #1-3 OKM+LS iPSC lines by using RT-PCR. Gapdh was used as a 
loading control. The primer sets that were used are summarized in Supplementary 
Table 1. (C) Expression of pluripotent marker proteins by using immunostaining. The 
expression of Nanog, Sox2, Stella and SSEA1 was detected as red signals. The insets 
are used to show nuclei visualized by using 4’, 6-Diamidino-2-Phenylindole (DAPI). 
(D) The contribution of OKM+LS- iPSCs derivatives in a mouse E12.5 #2 chimeric 
embryo. The iPSC derivatives were visualized as being blue cells by using X-gal 
staining. Germ cells derived from iPSCs were detected as Oct4-GFP-positive cells in 
the genital ridges (lower panels). 









